Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
MicroTech Medical (Hangzhou) Co., Ltd. Class H ( (HK:2235) ) has issued an update.
MicroTech Medical (Hangzhou) Co., Ltd. has announced that its board of directors will hold a meeting on August 29, 2025, to review and approve the unaudited interim results for the first half of the year and consider the recommendation of an interim dividend. This meeting could have implications for the company’s financial performance and shareholder returns.
The most recent analyst rating on (HK:2235) stock is a Sell with a HK$4.60 price target. To see the full list of analyst forecasts on MicroTech Medical (Hangzhou) Co., Ltd. Class H stock, see the HK:2235 Stock Forecast page.
More about MicroTech Medical (Hangzhou) Co., Ltd. Class H
MicroTech Medical (Hangzhou) Co., Ltd. is a joint stock company based in the People’s Republic of China, operating in the medical industry. The company focuses on developing and providing medical products and services.
Average Trading Volume: 201,885
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.95B
For an in-depth examination of 2235 stock, go to TipRanks’ Overview page.